|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jordan VC and O'Malley BW: Selective
estrogen-receptor modulators and antihormonal resistance in breast
cancer. J Clin Oncol. 25:5815–5824. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jordan VC and Murphy CS: Endocrine
pharmacology of antiestrogens as antitumor agents. Endocr Rev.
11:578–610. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ring A and Dowsett M: Mechanisms of
tamoxifen resistance. Endocr Relat Cancer. 11:643–658. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davies C, Godwin J, Gray R, Clarke M,
Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, et al Early
Breast Cancer Trialists' Collaborative Group (EBCTCG): Relevance of
breast cancer hormone receptors and other factors to the efficacy
of adjuvant tamoxifen: Patient-level meta-analysis of randomised
trials. Lancet. 378:771–784. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim S, Lee J, Oh SJ, Nam SJ and Lee JE:
Differential effect of EGFR inhibitors on tamoxifen-resistant
breast cancer cells. Oncol Rep. 34:1613–1619. 2015.PubMed/NCBI
|
|
7
|
Maxwell PJ, Gallagher R, Seaton A, Wilson
C, Scullin P, Pettigrew J, Stratford IJ, Williams KJ, Johnston PG
and Waugh DJ: HIF-1 and NF-kappaB-mediated upregulation of CXCR1
and CXCR2 expression promotes cell survival in hypoxic prostate
cancer cells. Oncogene. 26:7333–7345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collins TS, Lee LF and Ting JP: Paclitaxel
up-regulates interleukin-8 synthesis in human lung carcinoma
through an NF-kappaB- and AP-1-dependent mechanism. Cancer Immunol
Immunother. 49:78–84. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waugh DJ and Wilson C: The interleukin-8
pathway in cancer. Clin Cancer Res. 14:6735–6741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kassim SK, El-Salahy EM, Fayed ST, Helal
SA, Helal T, Azzam ED and Khalifa A: Vascular endothelial growth
factor and interleukin-8 are associated with poor prognosis in
epithelial ovarian cancer patients. Clin Biochem. 37:363–369. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mayerhofer K, Bodner K, Bodner-Adler B,
Schindl M, Kaider A, Hefler L, Zeillinger R, Leodolter S, Joura EA
and Kainz C: Interleukin-8 serum level shift in patients with
ovarian carcinoma undergoing paclitaxel-containing chemotherapy.
Cancer. 91:388–393. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miller LJ, Kurtzman SH, Wang Y, Anderson
KH, Lindquist RR and Kreutzer DL: Expression of interleukin-8
receptors on tumor cells and vascular endothelial cells in human
breast cancer tissue. Anticancer Res. 18(1A): 77–81.
1998.PubMed/NCBI
|
|
13
|
Chavey C, Bibeau F, Gourgou-Bourgade S,
Burlinchon S, Boissière F, Laune D, Roques S and Lazennec G:
Oestrogen receptor negative breast cancers exhibit high cytokine
content. Breast Cancer Res. 9:R152007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Freund A, Chauveau C, Brouillet JP, Lucas
A, Lacroix M, Licznar A, Vignon F and Lazennec G: IL-8 expression
and its possible relationship with estrogen-receptor-negative
status of breast cancer cells. Oncogene. 22:256–265. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freund A, Jolivel V, Durand S, Kersual N,
Chalbos D, Chavey C, Vignon F and Lazennec G: Mechanisms underlying
differential expression of interleukin-8 in breast cancer cells.
Oncogene. 23:6105–6114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martin D, Galisteo R and Gutkind JS:
CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF)
expression and the autocrine activation of VEGFR2 in endothelial
cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1)
complex. J Biol Chem. 284:6038–6042. 2009. View Article : Google Scholar :
|
|
17
|
Li A, Varney ML, Valasek J, Godfrey M,
Dave BJ and Singh RK: Autocrine role of interleukin-8 in induction
of endothelial cell proliferation, survival, migration and MMP-2
production and angiogenesis. Angiogenesis. 8:63–71. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Knowlden JM, Hutcheson IR, Jones HE,
Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE and Nicholson
RI: Elevated levels of epidermal growth factor receptor/c-erbB2
heterodimers mediate an autocrine growth regulatory pathway in
tamoxifen-resistant MCF-7 cells. Endocrinology. 144:1032–1044.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Z, Yang WM, Chen LP, Yang DH, Zhou Q,
Zhu J, Chen JJ, Huang RC, Chen ZS and Huang RP: Enhanced
chemosensitization in multidrug-resistant human breast cancer cells
by inhibition of IL-6 and IL-8 production. Breast Cancer Res Treat.
135:737–747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Wang Y, Gao Y, Shao J, Zhang XJ
and Yao Z: Reciprocal regulation of 17beta-estradiol, interleukin-6
and interleukin-8 during growth and progression of epithelial
ovarian cancer. Cytokine. 46:382–391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sansone P, Storci G, Giovannini C,
Pandolfi S, Pianetti S, Taffurelli M, Santini D, Ceccarelli C,
Chieco P and Bonafé M: p66Shc/Notch-3 interplay controls
self-renewal and hypoxia survival in human stem/progenitor cells of
the mammary gland expanded in vitro as mammospheres. Stem Cells.
25:807–815. 2007. View Article : Google Scholar
|
|
22
|
Korkaya H, Paulson A, Charafe-Jauffret E,
Ginestier C, Brown M, Dutcher J, Clouthier SG and Wicha MS:
Regulation of mammary stem/progenitor cells by
PTEN/Akt/beta-catenin signaling. PLoS Biol. 7:e10001212009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rody A, Karn T, Liedtke C, Pusztai L,
Ruckhaeberle E, Hanker L, Gaetje R, Solbach C, Ahr A, Metzler D, et
al: A clinically relevant gene signature in triple negative and
basal-like breast cancer. Breast Cancer Res. 13:R972011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benoy IH, Salgado R, Van Dam P, Geboers K,
Van Marck E, Scharpé S, Vermeulen PB and Dirix LY: Increased serum
interleukin-8 in patients with early and metastatic breast cancer
correlates with early dissemination and survival. Clin Cancer Res.
10:7157–7162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh B, Berry JA, Vincent LE and Lucci A:
Involvement of IL-8 in CoX-2-mediated bone metastases from breast
cancer. J Surg Res. 134:44–51. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh JK, Simões BM, Howell SJ, Farnie G
and Clarke RB: Recent advances reveal IL-8 signaling as a potential
key to targeting breast cancer stem cells. Breast Cancer Res.
15:2102013. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan A, Yang PC, Yu CJ, Chen WJ, Lin FY,
Kuo SH and Luh KT: Interleukin-8 messenger ribonucleic acid
expression correlates with tumor progression, tumor angiogenesis,
patient survival, and timing of relapse in non-small-cell lung
cancer. Am J Respir Crit Care Med. 162:1957–1963. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie K: Interleukin-8 and human cancer
biology. Cytokine Growth Factor Rev. 12:375–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mukaida N, Okamoto S, Ishikawa Y and
Matsushima K: Molecular mechanism of interleukin-8 gene expression.
J Leukoc Biol. 56:554–558. 1994.PubMed/NCBI
|
|
30
|
Scherle PA, Jones EA, Favata MF, Daulerio
AJ, Covington MB, Nurnberg SA, Magolda RL and Trzaskos JM:
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin
E2 production in lipopolysaccharide-stimulated monocytes. J
Immunol. 161:5681–5686. 1998.PubMed/NCBI
|
|
31
|
Aupperle K, Bennett B, Han Z, Boyle D,
Manning A and Firestein G: NF-kappa B regulation by I kappa B
kinase-2 in rheumatoid arthritis synoviocytes. J Immunol.
166:2705–2711. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sueoka H, Hirano T, Uda Y, Iimuro Y,
Yamanaka J and Fujimoto J: Blockage of CXCR2 suppresses tumor
growth of intrahepatic cholangiocellular carcinoma. Surgery.
155:640–649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ginestier C, Liu S, Diebel ME, Korkaya H,
Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum
D, et al: CXCR1 blockade selectively targets human breast cancer
stem cells in vitro and in xenografts. J Clin Invest. 120:485–497.
2010. View
Article : Google Scholar : PubMed/NCBI
|
